News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,108 Results
Type
Article (40874)
Company Profile (267)
Press Release (679957)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204653)
Career Advice (2022)
Deals (35531)
Drug Delivery (110)
Drug Development (81373)
Employer Resources (173)
FDA (16401)
Job Trends (14941)
News (346349)
Policy (32722)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49575)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16666)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4751)
Cardiovascular disease (395)
Career advice (1707)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69492)
Collaboration (1666)
Company closure (4)
Compensation (1141)
Complete response letters (52)
COVID-19 (2708)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6151)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6669)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (226)
Earnings (90036)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117177)
Executive appointments (958)
FDA (19474)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (582)
GLP-1 (962)
Government (4652)
Grass and pollen (6)
Guidances (383)
Healthcare (18868)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2966)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (546)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (776)
MASH (161)
Medical device (13754)
Medtech (13806)
Mergers & acquisitions (19950)
Metabolic disorders (1251)
Multiple sclerosis (156)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2865)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4509)
Now hiring (65)
Obesity (587)
Opinion (256)
Ovarian cancer (164)
Pain (196)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (471)
Peanut (55)
People (58806)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21667)
Phase 2 (30585)
Phase 3 (22789)
Pipeline (5084)
Policy (278)
Postmarket research (2564)
Preclinical (9190)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (814)
Real estate (5953)
Recruiting (69)
Regulatory (24411)
Reports (51)
Research institute (2383)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (86)
Weight loss (377)
Women's health (87)
Worklife (18)
Date
Today (22)
Last 7 days (600)
Last 30 days (1961)
Last 365 days (29745)
2026 (2833)
2025 (30173)
2024 (35215)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54084)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39185)
Australia (6405)
California (11154)
Canada (3250)
China (1082)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84415)
Florida (1661)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (851)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7991)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2967)
New Mexico (28)
New York (2941)
North Carolina (1436)
North Dakota (8)
Northern California (5435)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4340)
Tennessee (172)
Texas (1722)
United States (39549)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,108 Results for "vaxart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
HHS Freezes Vaxart’s Oral COVID-19 Vaccine, Again
The stop order came on Aug. 5, the same day Health Secretary Robert F. Kennedy Jr. terminated 22 mRNA vaccine projects under the Biomedical Advanced Research and Development Authority, though Vaxart’s candidate is protein-based.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
January 9, 2026
·
1 min read
Press Releases
Vaxart to Host Upcoming November 2025 Conference Calls
November 10, 2025
·
2 min read
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
April 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
November 14, 2025
·
12 min read
Press Releases
Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program
November 5, 2025
·
12 min read
Press Releases
Vaxart Announces Adjournment of Special Meeting of Stockholders
September 9, 2025
·
6 min read
Press Releases
Vaxart Appoints W. Mark Watson as Lead Independent Director
September 18, 2025
·
6 min read
Press Releases
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
October 21, 2025
·
1 min read
Press Releases
Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025
October 9, 2025
·
4 min read
1 of 72,111
Next
